Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformationHer ...

Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, today announced the appointment of former Academy of Family Physicians ...

Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusionAstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) ...

The outpatient clinics market is projected to expand at a compound annual growth rate (CAGR) of 8% over the forecast period.

The breast lesion localization devices market is showing consistent expansion, with an estimated compound annual growth rate of approximately 7% over the forecast period. This growth is fueled by the ...

Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering ·         Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM London, UK and Chicago, ...

MSF: Ethiopia’s first R21 malaria vaccine rollout, a global first in a refugee camp Addis Ababa – 15 December 2025: Médecins Sans Frontières (MSF) has completed the first full round of R21 malaria ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announces the completion of cohort 2a in the clinical Phase I trial evaluating the drug candidate 177Lu-AKIR001.

German specialist in mixing, dispersing and powder-wetting technologies, is significantly strengthening its operations in India with the opening of a new facility in Bangalore. The expansion, which ...

Fida Biosystems welcomes Swedish Fåhraeus Startup and Growth Fund (FSG) as a new investor, while EIFO strengthens its commitment to the Danish innovator.Fida Biosystems, a Danish life science tools ...

BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving ...

Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that Gijs van den Brink, MD, PhD, has been ...